Проблеми цукрознижувальної терапії за цукрового діабету 2-го типу: уроки «мегатрайлів»

І. І. Смирнов

doi:10.24026/1818-1384.1(30).2010.96236

Автор(и)

І. І. Смирнов Харківський національний медичний університет, Харків, Україна

DOI:

https://doi.org/10.24026/1818-1384.1(30).2010.96236

Ключові слова:

diabetes mellitus, treatment, glycemic control, hypoglycemia, cardiovascular risk

Анотація

Results of randomized multicentral and long-term clinical trials devoted to the role of rigorous glycemic control in occurence and progression of micro- and macrovascular complicatoins of diabetes mellitus are analized. Euglycemia as therapeutic goal is not only desirable but also necessary. However minimization of hypoglycemic risk must be key aspect of planning treatment for every particular patient. All risk factors of cardiovascular events should be taken into consideration during implementation of therapeutic complex.

Біографія автора

І. І. Смирнов, Харківський національний медичний університет, Харків

I. Smirnov

Посилання

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) // Lancet. — 1998. — V.352. — P. 837–853. https://doi.org/10.1016/s0140-6736(98)07019-6

University Group Diabetes Program (UGDP). A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes // Diabetes. — 1970. — V. 19, Suppl. 2. — P. 747–830.

Genuth S., Eastman R., Kahn R., American Diabetes Association et al. Implications of the United Kingdom prospective diabetes study // Diabetes Care. — 2003. — V. 26. — P. S28–S32. https://doi.org/10.2337/diacare.26.2007.s28

Ohkubo Y., Kishikawa H., Araki E. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-years study // Diabetes Res. Clin. Pract. — 1995. — V. 28. — P. 103–117. https://doi.org/10.1016/0168-8227(95)01064-k

Dormandy J.A., Charbonnel B., Eckland D.J. Secondary prevention of macrovascular events in patients with type 2 dia be tes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial // Lancet. — 2005. — V. 366. — P. 1279–1289. https://doi.org/10.1016/s0140-6736(05)67528-9

The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes // N. Engl. J. Med. — 2008. — V. 358. — P. 2545–2559. https://doi.org/10.1056/nejmoa0802743

The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes // N. Engl. J. Med. — 2008. — V. 358 — P. 2560–2572. https://doi.org/10.1056/nejmoa0802987

Duckworth W.C., Abrarira C., Moritz T. et al. Glucose control and vascular complications in veterans with type 2 diabetes // N. Engl. J. Med. — 2009. — V. 360. — P. 129–139. https://doi.org/10.1056/nejmoa0808431

Ong K.L., Cheung B.M., Wong L.Y., Wat N.M., Tan K.C., Lam K.S. Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999–2004 // Ann. Epidemiol. — 2008. — V. 18. — P. 222–229. https://doi.org/10.1016/j.annepidem.2007.10.007

Dale A.C., Vatten L.J., Nilsen T.I., Midthjell K., Wiseth R. Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study // BMJ. — 2008. — V. 337. — P. a236-a236. https://doi.org/10.1136/bmj.39582.447998.be

The Diabetes Control and Complications Trial Research Group. The effect of intensive therapy of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus // N. Engl. J. Med. — 1993. V. 329. — P. 977–986. https://doi.org/10.1056/nejm199309303291401

Klein R., Knudston M.D., Lee K.E., Gangnon R., Klein B.E. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII: the twenty-five-year progression of retinopathy in persons with type 1 diabetes // Ophthalmology. — 2008. — V. 115. — P. 1859–1868. https://doi.org/10.1016/j.ophtha.2008.08.023

Girach A., Manner D., Porta M. Diabetic microvascular complications: can patients at risk be identified? A review // Int. J. Clin. Pract. — 2006. — V. 60. — P. 1471–1483. https://doi.org/10.1111/j.1742-1241.2006.01175.x

Stratton I.M., Cull C.A., Adler A.I., Matthews D.R., Neil H.A., Holman R.R. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75) // Diabetologia. — 2006. — V. 49. — P. 1761–1769. https://doi.org/10.1007/s00125-006-0297-1

Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes // N. Engl. J. Med. — 2003. — V. 348. — P. 383–393. https://doi.org/10.1056/nejmoa021778

Kilo C., Miller J.P., Williamson J.R. The Achilles heel of the University Group Diabetes Program // JAMA. — 1980. — V. 243. — P. 450–457. https://doi.org/10.1001/jama.1980.03300310038020

UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group // Lancet. — 1998. — V. 352. — P. 854–865. https://doi.org/10.1016/s0140-6736(98)07037-8

Evans J.M., Ogston S.A., Emslie-Smith A., Morris A.D. Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin // Diabetologia. — 2006. — V. 49. — P. 930–936. https://doi.org/10.1007/s00125-006-0176-9

Kronmal R.A., Barzilay J.I., Smith N.L. et al. Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989–2001 // PLoS. Med. — 2006. V. 3. — P. E400. https://doi.org/10.1371/journal.pmed.0030400

Anselmino M., Ohrvik J., Malmberg K., Standl E., Ryden L., Euro Heart Survey Investigators. Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart // Eur. Heart. J. — 2008. — V. 29. — P. 177–184. https://doi.org/10.1093/eurheartj/ehm519

Abraria C., Duckworth W.C., Moritz T. et al. Glycaemic separation and risk factor control in the Veteran Affairs Diabetes Trial: an interim report // Diabetes Obes. Metab. — 2009. — V. 11. — P. 150–156. https://doi.org/10.1111/j.1463-1326.2008.00933.x

Byington R.P. for the ACCORD Study Group (2008) Relationship between post-randomization hypoglycaemia and ACCORD mortality outcomes. Available from http://webcasts.prous.com/netadmin/webcast_veiwer/Preview.aspx?type=0&lid=3753, assessed 20 March 2009.

Hilsted J. Cardiovascular changes during hypoglycaemia // Clin. Physiol. — 1993. — V. 13. — P. 1–10. https://doi.org/10.1111/j.1475-097x.1993.tb00312.x

Avogaro A., Vigili de Kreutzenberg S., Negut C., Tiengo A., Scognamiglio R. Diabetic cardiomyopathy: a metabolic perspective // Am. J. Cardiol. — 2004. — V. 93. — P. 13–16. https://doi.org/10.1016/j.amjcard.2003.11.003

Landstedt-Hallin L., Englund A., Adamson U., Lins P.E. Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus // J. Intern. Med. — 1999. — V. 246. — P. 299–307. https://doi.org/10.1046/j.1365-2796.1999.00528.x

Monnier L., Mas E., Ginet C. et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycaemia in patients with type 2 diabetes // JAMA. — 2006. — V. 295. — P. 1681–1687. https://doi.org/10.1001/jama.295.14.1681

Vinik A.I., Ziegler D. Diabetic cardiovascular autonomic neuropathy // Circulation. — 2007. — V. 115. — P. 387–397. https://doi.org/10.1161/circulationaha.106.634949

White N.H., Sun W., Cleary P.A., Danis R.P. et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial // Arch. Ophthalmol. — 2008. — V. 126. — P. 1707–1715. https://doi.org/10.1001/archopht.126.12.1707

Nathan D.M., Cleary P.A., Backlund J.Y. Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes // N. Engl. J. Med. — 2005. — V. 353. — P. 2643–2653. https://doi.org/10.1056/nejmoa052187

Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes // N. Engl. J. Med. — 2008. — V. 359. — P. 1577–1589. https://doi.org/10.1056/nejmoa0806470

Holman R.R., Paul S.K., Bethel M.A., Neil H.A., Matthews D.R. Long-term follow-up after tight control of blood pressure in type 2 diabetes // N. Engl. J. Med. — 2008. — V. 359. — P. 1565–1576. https://doi.org/10.1056/nejmoa0806359

Duckworth W. (2008) VADT: results. Available from http://webcasts.prous. com/netadmin/webcast_veiwer/Preview.aspx?type=0&lid=3853, assesed 20 March 2009.

Juutilainen A., Lehto S., Rennemaa T., Pyorala K., Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women // Diabetes Care. — 2007. — V. 30. — P. 292–299. https://doi.org/10.2337/dc06-1747

Reaven P.D., Emanuele N., Moritz T., Veterans Affairs Diabetes Trial et al. Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT) // Diabetes Care. — 2008. — V. 31. — P. 952–957. https://doi.org/10.2337/dc07-1926

Moreno P.R., Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis // J. Am. Coll. Cardiol. — 2004. — V. 44. — P. 2293–2300. https://doi.org/10.1016/j.jacc.2004.07.060

Brownlee M. The pathobiology of diabetic complications: a unifying mechanism // Diabetes. — 2005. — V. 54. — P. 1615–1625. https://doi.org/10.2337/diabetes.54.6.1615

http://www.diabetes.org/for-media/pr-intense-blood-glucose-control-yields-no-significant-efect-on- cvd-reduction.jsp, assessed on 2 September 2006.

The DCCT Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial // Arch. Ophthalmol. — 1998. — V. 116. — P. 874–886. https://doi.org/10.1001/archopht.116.7.874

Lauritzen T., Frost-Larsen K., Larsen H.W., Deckert T. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics // Lancet. — 1983. — V. 321. — P. 200–204. https://doi.org/10.1016/s0140-6736(83)92585-0

Del Prato S., Felton A.M., Munro N., Nesto R., Zimmet P., Zinman N. Global Partnership for Effective Diabetes Management. Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal // Int. J. Clin. Pract. — 2005. — V. 59. — P. 1345–1355. https://doi.org/10.1111/j.1742-1241.2005.00674.x

Lebovitz H.Е., Austin M.M., Blonde L., ACE/AACE Diabetes Recommendations Implementation Writing Committee et al. ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations // Endocr. Pract. — 2006. — V. 12, Suppl 1. — P. 6–12. https://doi.org/10.4158/ep.12.s1.6